New Player In The Fight Against Resistant Fungal Infections In Phase 3 Trial
Rezofungin hopes to fight increasingly deadly hospital-acquired fungal infections.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news